Literature DB >> 25126009

An epidemiological study on trigger factors and quality of life in psoriatic patients.

Alert Xhaja1, Entela Shkodrani1, Silvan Frangaj1, Loreta Kuneshka1, Ermira Vasili1.   

Abstract

OBJECTIVE: to evaluate the role of stress, tobacco, drugs, infections, allergies, heredity, alcohol, hormones and skin aggressions as trigger factors and the impact on quality of life in a sample of psoriasis patients.
METHODS: a transversal study performed in 90 patients affected by psoriasis between January and November 2012 at the "Nene Tereza" University Hospital, Tirane, Albania, based on two scored questionnaires.
RESULTS: more than 70 % of patients reported that stressful events caused a flare- up of their psoriasis (p< 0.05). More than 60% of males and 20% of females were smokers (p< 0.05). About 20% of our patients were taking one or more of the medications listed in the questionnaire (p> 0.05). About 20% of patients reported having had recurrent infections (p<0,05). About 80% of males patients consumed alcohol (p<0,05). More than 40% reported a relative with psoriasis. Statistical comparison of the group that reported skin aggressions with the group that did not revealed a significant difference (p<0,05). Only a few of them reported to have allergies (p>0,05). About 36% of females reported that hormonal changes (puberty and menopause) exacerbated their psoriasis (p<0,05). More than 40% of patients reported that psoriasis seriously affects their quality of life.
CONCLUSION: stress, tobacco, infections, heredity, alcohol, hormonal changes and skin aggressions were confirmed as trigger factors for psoriasis in the present sample. Allergies and the investigated drugs seemed not to have any influence in flare-ups. We found that psoriasis had a serious impact in the quality of life in over of 40% of the patients interviewed.

Entities:  

Keywords:  Albania; psoriasis; quality of life; trigger factors

Year:  2014        PMID: 25126009      PMCID: PMC4130688          DOI: 10.5455/msm.2014.26.168-171

Source DB:  PubMed          Journal:  Mater Sociomed        ISSN: 1512-7680


1. INTRODUCTION

Psoriasis is a non-contagious chronic cutaneous inflammatory disease, with a genetic component. It affects 2-3 % of European population. While psoriasis can start at any age, there are two peaks of onset: one at around 20-30 years old subjects, and the other at subjects of over 50 years of age. (1-9) It is a disease without vital prediction, but with a major impact on life quality and self-value. Epidermal proliferation is its earliest recognized pathogenetic characteristic. DNA synthesis and mitotic activity are dramatically increased in the basal layer. (10-14) The cells divide every 1.5 days and move rapidly to the surface over 3 – 4 days, where they are shed in large amounts as incompletely keratinized scales. A special feature of psoriatic lesions is the migration of neutrophils into the involved epidermis. Intact neutrophils collect in the sub corneal space, forming micro-abscesses. (27-29). Large numbers of CD4+ and CD8+ T cells are found in the epidermis and upper dermis. They appear to play a key role in the development of the cutaneous manifestations of the disease. (15-20) T cells in psoriasis lesions release Th1 / Th17 mediators, such as IFN-γ, IL2, IL17, IL23 and TNF-α. These mediators act on keratinocytes and other cells in the skin, activating them and inducing the formation of lesions. (21-26). The inheritance of psoriasis is clearly polygenic or multi-factorial. Most likely, multiple psoriasis alleles encoded by several genes are required for the disease to become manifested. (30-34). Many exogenous or endogenous factors can trigger the eruption of psoriasis. Known exogenous triggers are skin aggression (35), infections (36-38), alcohol and tobacco (39-45), stress (43-46), drugs (lithium, beta-blockers, antimalarials, ACE-inhibitors, NSAIDs). (47-54) Endogenous triggers are hormonal changes (55,56) and allergies (57, 58).

2. PATIENTS AND METHODS

The study was conducted in the dermatology department of the “Nene Teresa” University Hospital, Tirane, during the period from January to November 2012. A sample of 90 patients with psoriasis, 45 men and 45 women above 18 years-old were included, either with recurrent disease or their first flare-up. The interviews were carried out using two questionnaires: the first inquiring about potential trigger factors and the second assessing the quality of life. The aim was to identify the importance of trigger factors in the outburst and exacerbation of psoriasis in our sample and the impact of the disease on their quality of life. Questionnaire on potential trigger factors CV-50 questionnaire for quality-of-life assessment

3. STATISTICAL ANALYSIS

Statistical analyses were performed using SPSS for Windows. The significance between variables was tested using the chi-squared statistical test (χ2 test).

4. RESULTS

More than 70 % of patients reported that stressful events cause their psoriasis to flare-up of. Using the χ2 test, a significant difference was found between patients who experienced stressful events and those who did not (p< 0.05). This confirmed stress as a trigger factor in both males and females of our sample. More than 60% of males and 20% of females were smokers. Statistical analysis yielded a significant difference between smoking and non-smoking females (p< 0.05, regardless of the number of cigarettes). Similar results came out comparing smoking and non-smoking males (p=0.026). Smoking is a trigger factor for both males and females in our sample. About 80% of males patients consumed alcohol. Statistical comparison between the groups of drinkers and non-drinkers resulted statistically significant (p<0,05). Alcohol is a trigger factor in male patients of our sample. About 20% of our patients were taking one or more of the medications listed in the questionnaire. Comparison of the group that received drugs (at least one) with the group that did not receive any resulted statistically insignificant (p> 0.05). About 20% of patients reported having had recurrent infections. Comparison of the group reporting recurrent infections with the group not reporting resulted statistically significant (p<0,05). Recurrent infections are trigger factors in the patients of our sample. Statistical comparison between the groups reporting skin aggressions and not resulted significant (p<0,05). Skin aggressions are a trigger factor for psoriasis in our sample. Only a few patients reported having allergies. Statistically it resulted not significant (p>0,05). More than 40% reported to have a relative with psoriasis. About 36% of females reported the effect of hormonal changes in the exacerbation of psoriasis. Hormonal changes resulted statistically significant in females (p<0,05). They are a trigger factor for psoriasis in female patients of our sample. In this study more than 40% of patients reported that psoriasis seriously affects their life. The most affected areas are everyday activities, professional activities, relationships with family members and friends. Most of the patients avoid public interaction, dress to hide their condition and feel like outcasts (64%). Psoriasis affects daily interpersonal interactions in four out of ten (38%) interviewed subjects. For those with severe psoriasis, this increases to 57%. Three fourths (74%) do not like being in public during a flare- up. One third (37%) admit that the disease affects work or school.

5. DISCUSSION

In the recent years, there has been an increase in the number of instruments for assessing the quality of life of psoriasis patients and the role of risk factors in the onset of disease. They can be subdivided into two groups: generic and specific. Generic ones assess the quality of life outside a clinical context. These questionnaires find application in the general population or in various clinical pathologies. Specific questionnaires apply to a single disease only. The CV-50 questionnaire is a specific instrument dedicated to cutaneous diseases and comprises 18 questions. It can be used to assess and compare the quality of life among different skin conditions. The score ranges from 10 to 50, the higher the figures, the deeper the impact on quality of life. The CV-50 questionnaire assesses the impact of psoriasis in four directions: daily activities, job or school, entertainment and personal relations. The patient must recollect his last week and gauge the influence of psoriasis in each of these fields. Based on the answers yielded by the questionnaire, the fields on which psoriasis had the greatest impact were daily activities and relaxing activities. The results pointed out that the biggest emotional upsets were noted when the disease was located in the face, neck and genital region. For most cutaneous diseases, risk factors are multiple and often connected with each other. A case-control study represents one of the epidemiological-analytical methods used to test the correlation between risk factors and specific disease frequency. The genetic bases of psoriasis are well-known, its occurrence being under the influence of various factors that can cause the onset, aggravation or remission as well as contribute to chronicization and therapeutic failure. The present study has been designed to investigate the correlation with selected risk factors: alcohol consumption, smoking, stress, medications, recurrent infections, family history, cutaneous aggressions, allergies and hormonal changes. The study showed that 50% of psoriasis patients blamed stress as the cause of their disease, with a significant difference. Various studies related to the assessment of stressful life events have pointed out that stress can induce the occurrence of the disease, with early onset psoriasis (<40 y.o.) more frequently related to psychological factors such as stress. (43, 44). Smoking seriously affects internal organs, especially the heart and lungs, but also influences the external appearance including the skin, weight and corporeal forms. The present study, like many similar ones (41-45), revealed a significant difference between smokers and non-smokers, especially among women. Many studies showed that alcohol consumption is closely correlated to the onset of disease (39-43, 45). 80 % of the male psoriasis patients included in the present study consumed alcohol in various amounts. As for hormonal changes, as in other studies (56), it was noted that they influenced in the aggravation of disease in 36% of female patients. A vast number of clinical reports show that bacterial infections can induce the occurrence of psoriasis and it is well known that disease aggravations are often preceded by streptococcal infections. (36- 38) In the present study 20% of the patients confirmed that they had recurrent infections.

6. CONCLUSION

Stress, tobacco, infections, alcohol, hormones, skin aggressions were confirmed as trigger factors in this study. It was found that the disease affects the quality of life in more than 40% of patients. The scale of impairment from psoriasis is comparable to other chronic diseases like diabetes or asthma. It is important to point out that the same degree of gravity may have a different impact on different patients, depending on individual characteristics and lifestyles. It is crucial to evaluate the perception of the psoriatic patient about other medical conditions, disabilities and quality of life in order to tailor an adequate individual treatment schedule.
Table 1

Questionnaire on potential trigger factors

Table 2

CV-50 questionnaire for quality-of-life assessment

  59 in total

1.  Structural aspects of initial psoriatic lesions.

Authors:  O Braun-Falco; E Christophers
Journal:  Arch Dermatol Forsch       Date:  1974

2.  Drug exposure and psoriasis vulgaris: case-control and case-crossover studies.

Authors:  Arnon D Cohen; Dan Y Bonneh; Haim Reuveni; Daniel A Vardy; Lechaim Naggan; Sima Halevy
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

3.  IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis.

Authors:  James G Krueger; Scott Fretzin; Mayte Suárez-Fariñas; Patrick A Haslett; Krista M Phipps; Gregory S Cameron; Juliet McColm; Artemis Katcherian; Inna Cueto; Traci White; Subhashis Banerjee; Robert W Hoffman
Journal:  J Allergy Clin Immunol       Date:  2012-06-05       Impact factor: 10.793

4.  T cells involved in psoriasis vulgaris belong to the Th1 subset.

Authors:  J F Schlaak; M Buslau; W Jochum; E Hermann; M Girndt; H Gallati; K H Meyer zum Büschenfelde; B Fleischer
Journal:  J Invest Dermatol       Date:  1994-02       Impact factor: 8.551

5.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.

Authors:  K Uyemura; M Yamamura; D F Fivenson; R L Modlin; B J Nickoloff
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

6.  The prevalence of psoriasis in Denmark.

Authors:  F Brandrup; A Green
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

Review 7.  Epidemiology of psoriasis.

Authors:  Luigi Naldi
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2004-06

8.  Risk factors for psoriasis: A case-control study.

Authors:  Slavenka Jankovic; Milena Raznatovic; Jelena Marinkovic; Janko Jankovic; Natasa Maksimovic
Journal:  J Dermatol       Date:  2009-04-28       Impact factor: 4.005

9.  Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha.

Authors:  Onur Boyman; Hans Peter Hefti; Curdin Conrad; Brian J Nickoloff; Mark Suter; Frank O Nestle
Journal:  J Exp Med       Date:  2004-02-23       Impact factor: 14.307

10.  IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.

Authors:  Jason R Chan; Wendy Blumenschein; Erin Murphy; Caroline Diveu; Maria Wiekowski; Susan Abbondanzo; Linda Lucian; Richard Geissler; Scott Brodie; Alexa B Kimball; Daniel M Gorman; Kathleen Smith; Rene de Waal Malefyt; Robert A Kastelein; Terrill K McClanahan; Edward P Bowman
Journal:  J Exp Med       Date:  2006-10-30       Impact factor: 14.307

View more
  6 in total

1.  A study of the use of drugs in patients suffering from psoriasis and their impact on quality of life.

Authors:  V V Karamata; A M Gandhi; P P Patel; A Sutaria; M K Desai
Journal:  Indian J Pharmacol       Date:  2017 Jan-Feb       Impact factor: 1.200

2.  The Relationship between Spiritual Well-Being and Resilience in Patients with Psoriasis.

Authors:  Mohammadhossein RahimZahedi; Camellia Torabizadeh; Majid Najafi Kalyani; Seyed Alireza Moayedi
Journal:  Dermatol Res Pract       Date:  2021-03-26

Review 3.  Cytokine Modulators in Plaque Psoriasis - A Review of Current and Prospective Biologic Therapeutic Approaches.

Authors:  Marisa L Strychalski; Henry S Brown; Stephanie C Bishop
Journal:  JAAD Int       Date:  2022-08-27

4.  Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.

Authors:  Lakshi M Aldredge; Melodie S Young
Journal:  J Dermatol Nurses Assoc       Date:  2016-02-12

Review 5.  The role of hormones in the pathogenesis of psoriasis vulgaris.

Authors:  Iulia Ioana Roman; Anne-Marie Constantin; Mihaela Elena Marina; Remus Ioan Orasan
Journal:  Clujul Med       Date:  2016-01-15

6.  Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis.

Authors:  M Lebwohl; D Thaçi; R B Warren
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-02       Impact factor: 6.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.